At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 62 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Citicoline for Alcohol Dependence
University of Texas Southwestern Medical Center·interventional·Posted Feb 28, 2014·Updated Jul 24, 2018
In Brief
A Phase 4 clinical trial evaluating Placebo and Citicoline for Alcohol Dependence. Completed, enrolled 62 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if citicoline, as an add-on therapy, will help reduce alcohol use in outpatients with alcohol dependence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Dependence
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 2014
Enrollment StartApr 2014
Primary CompletionOct 2016
Study CompletionNov 2016
TodayJul 2026
First PostedFeb 28, 2014
Enrollment StartApr 1, 2014
Primary CompletionOct 1, 2016
Study CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.3 years ago
Interventions
Placebodrug
Inactive ingredient matching the active comparator in appearance
Citicolinedrug
Citicoline is an over-the-counter nutritional supplement that is used for neuroprotective effects. It is a naturally occurring neurochemical in the human body.